BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3265504)

  • 1. CD1 expression in B-CLL cells.
    Merle-Béral H; Boumsell L; Michel A; Blanc C; Debré P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):327-30. PubMed ID: 3265504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
    Merle-Beral H; Blanc C; Chastang C; Debre P
    Eur J Haematol; 1988 Sep; 41(3):197-203. PubMed ID: 3263283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1 expression on B-CLL lymphocytes.
    Merle-Beral H; Boumsell L; Michel A; Debré P
    Br J Haematol; 1989 Feb; 71(2):209-12. PubMed ID: 2784324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M241 (CD1) expression on B lymphocytes.
    Small TN; Knowles RW; Keever C; Kernan NA; Collins N; O'Reilly RJ; Dupont B; Flomenberg N
    J Immunol; 1987 May; 138(9):2864-8. PubMed ID: 3106492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
    Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
    Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: identification of a new B-cell subset.
    Delia D; Cattoretti G; Polli N; Fontanella E; Aiello A; Giardini R; Rilke F; Della Porta G
    Blood; 1988 Jul; 72(1):241-7. PubMed ID: 3260523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of normal and malignant CD5+ B lymphocytes.
    Riva M; Schena M; Bergui L; Tesio L; Gaidano G; Marchisio P; Caligaris-Cappio F
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):289-91. PubMed ID: 3265499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
    Han T; Ozer H; Minowada J
    Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4, CD8 and NK subsets in B-CLL.
    Vuillier F; Tortevoye P; Binet JL; Dighiero G
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):331-4. PubMed ID: 3265505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease.
    Tötterman TH; Carlsson M; Funderud S; Simonsson B; Oberg G; Nilsson K
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):279-81. PubMed ID: 3265498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
    Guy K; Docherty LJ; Dewar AE
    Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
    Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node biopsy in chronic lymphocytic leukemia: prognostic significance of histopathological, morphometry and immunohistological findings.
    Raphael M; Debré P; Guigui B; Binet JL
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):379-83. PubMed ID: 3265507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
    Molica S; Mannella A; Crispino G; Dattilo A; Levato D
    Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
    Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
    Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7, a B-cell-restricted antigen that identifies preactivated B cells.
    Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
    J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increased number of follicles containing activated CD69+ helper T cells and proliferating CD71+ B cells are found in H. pylori-infected gastric mucosa.
    Terrés AM; Pajares JM
    Am J Gastroenterol; 1998 Apr; 93(4):579-83. PubMed ID: 9576451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.